Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada

Business by 2FIRSTS.ai
Jan.09.2024
Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada
VPR Brands announces Turning Point Brands Canada as the exclusive distributor of its HoneyStick products in Canada.

VPR Brands (OTC: VPRB) recently announced that Turning Point Brands Canada (TPB) will serve as the exclusive distributor for its HoneyStick products in Canada.

 

VPR Brands (VPRB) is an e-cigarette manufacturer dedicated to introducing innovative products.

 

TPB is a Canadian marketing and distribution company in the field of tobacco, e-cigarettes, and alternative products.

 

HoneyStick is set to join TPB Canada's portfolio of leading global brand management, alongside iconic brands such as Zig-Zag, Clipper, Choice Leaf, HMP, Rebound, and Evolve, to enter the Canadian market.

 

In the future, TPB Canada will streamline the retail process by centralizing ordering, logistics, and warehousing in one location. This will ensure a steady supply of HoneyStick products and reduce delivery times, enabling faster product delivery across Canada.

 

Currently, HoneyStick has launched on the Canadian e-commerce platform tpbmarketplace. However, it is either marked as "sold out" or yet to be available on several other Canadian e-commerce platforms.

 

Mikail Fancy, Chief Operating Officer of Turning Point Brands Canada, expressed enthusiasm over the partnership with VPR Brands to bring HoneyStick to a wider audience in Canada. Fancy highlighted the combination of their expertise in marketing, sales, distribution, and logistics, along with the quality and innovation of HoneyStick products, as a perfect match. He emphasized their commitment to providing excellent service and support for retailers and consumers.

 

Daniel Hoff, Chief Operating Officer of VPR Brands, has stated that the collaboration with Turning Point Brands Canada is a significant milestone for HoneyStick in Canada. Their strong distribution network and successful experience in marketing, sales, and customer service make them an ideal partner to enhance our brand's presence and accessibility nationwide.

 

VPR is currently involved in a significant case regarding a legal dispute with IMiracle (Heaven Gifts). The main point of contention revolves around the usage rights of the term "Elf" on e-cigarette products.

 

VPR filed a lawsuit in October 2022 against the distributor Shenzhen Weibo Li Technology Co., Ltd and the manufacturer iMiracle (HK) Limited, alleging infringement of VPR's trademark rights on ELF during the sales of Elfbar. Elfbar is the most popular disposable e-cigarette brand among young users.

 

In response, Judge Cannon in the United States issued a temporary injunction on Chinese companies in February 2023, prohibiting them from selling any e-cigarette products bearing the name ELFBAR. Judge Cannon stated that there is currently "no dispute" that these companies intentionally infringed upon VPR's trademark rights.

 

Shenzhen V-Perfect and iMiracle have submitted their first document claiming that they can prove V-Perfect is not the original user of the ELF trademark. According to the documents submitted by these two companies on April 24th, they have discovered the true owner of the ELF trademark, another Chinese company called GD Sigelei Electronic Tech. This company first used the "ELF" to sell e-cigarette products in April 2016, almost a year and a half earlier than V-Perfect's first batch of ELF products.

 

In March of this year, two Chinese companies signed a trademark transfer agreement, claiming to have transferred the rights to the Elf trademark to iMiracle. Based on this, they have requested Judge Cannon to revoke the temporary injunction.

 

Another important document claims that VPR has utilized a court order prohibiting them from manufacturing ELFBAR in order to seek market share. According to the document from May, VPR has launched a "blatantly imitated" ELFBAR disposable e-cigarette, clearly copying iMiracle's product. Both of these Chinese companies argue that these inferior counterfeit products will confuse consumers, ultimately leading to ELFBAR losing market share and reputation.

 

Although both parties have informed the mediators that Judge Cannon's decision on these two motions will "guide their positions for settlement," the case remains at a standstill, waiting for the Chinese companies to appeal to the Federal Circuit in an attempt to overturn the injunction. These two Chinese companies are dissatisfied with the temporary ban and stated in their submission to the Federal Circuit that the injunction is erroneous and has resulted in them losing millions of dollars.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italy's Guardia di Finanza announced on October 28 that officers in Latina province had seized approximately 4.3 million e-cigarettes and smoking accessories at an unauthorized warehouse in an operation involving restrictions on the possession and sale of tobacco-related products. Another 300,000 suspected counterfeit or unsafe items were confiscated during separate inspections, bringing total seizures across the operations to more than 4.6 million products. Twenty-eight people were reported to judicial authorities over suspected smuggling and counterfeiting offenses. Officials did not disclose separate vape quantities, the value of the merchandise or alleged violations associated with individual brands.
Enforcement
Oct.29